Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China

BACKGROUND AND OBJECTIVE: To evaluate the cost-effectiveness of new anticoagulants and warfarin in the prevention of stroke in Chinese patients with atrial fibrillation (AF). METHODS: The Markov model was constructed to compare patients’ quality-adjusted life-years (QALYs) using drug cost, the cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Hongtao, Cui, Can, Cui, Xiangli, Liu, Yi, Li, Dandan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841891/
https://www.ncbi.nlm.nih.gov/pubmed/33509171
http://dx.doi.org/10.1186/s12913-021-06084-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841891/
https://www.ncbi.nlm.nih.gov/pubmed/33509171
http://dx.doi.org/10.1186/s12913-021-06084-1

Ejemplares similares